10.1111/j.1476-5381.2009.00170.x
Lobsiger CS, 2007, Nat Neurosci, 10, 1355, 10.1038/nn1988
Milligan E, 2009, Nat Rev Neurosci, 10, 23, 10.1038/nrn2533
Romero-Sandoval EA, 2008, Curr Opin Invest Drugs, 9, 726
Huang Z, 2006, Life Sci, 78, 2663, 10.1016/j.lfs.2005.10.026
Gibson L, 2006, Eur J Pharmacol, 538, 39, 10.1016/j.ejphar.2006.02.053
Ohashi M, 1993, Int Arch Allergy Immunol, 101, 288, 10.1159/000236460
Ohtsu H, 1989, Int Arch Allergy Appl Immunol, 89, 306, 10.1159/000234965
Feng J, 2004, Mult Scler, 10, 494, 10.1191/1352458504ms1070oa
Choi SH, 1989, J Pharmacobiodyn, 12, 517, 10.1248/bpb1978.12.517
Souness JE, 1994, Br J Pharmacol, 111, 1081, 10.1111/j.1476-5381.1994.tb14855.x
Chihara J, 1998, Ann Allergy Asthma Immunol, 81, 448, 10.1016/S1081-1206(10)63144-4
Kawasaki A, 1992, J Asthma, 29, 245, 10.3109/02770909209048938
Yoshioka A, 2000, J Neurochem, 74, 633, 10.1046/j.1471-4159.2000.740633.x
Yoshioka A, 1998, J Neurochem, 70, 2416, 10.1046/j.1471-4159.1998.70062416.x
Takuma K, 2001, Br J Pharmacol, 133, 841, 10.1038/sj.bjp.0704146
Mizuno T, 2004, Neuropharmacology, 46, 404, 10.1016/j.neuropharm.2003.09.009
Ledeboer A, 2007, Expert Opin Investig Drugs, 16, 935, 10.1517/13543784.16.7.935
Suzumura A, 1999, Brain Res, 837, 203, 10.1016/S0006-8993(99)01666-2
Fujimoto T, 1999, J Neuroimmunol, 95, 35, 10.1016/S0165-5728(98)00251-3
Wakita H, 2003, Brain Res, 992, 53, 10.1016/j.brainres.2003.08.028
Kagitani-Shimono K, 2005, J Neuroinflammation, 2, 10, 10.1186/1742-2094-2-10
Ladecola C, 2007, Nat Neurosci, 10, 1369, 10.1038/nn2003
Milligan ED, 2009, Nat Rev Neurosci, 10, 23, 10.1038/nrn2533
Ledeboer A, 2007, Neuron Glia Biol, 2, 279, 10.1017/S1740925X0700035X
Ellis AL, Wieseler J, Ramos K, A novel model of spinal cord injury: characterization of exaggerated pain behavior and glial activation Program No. 171.22. 2008; Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2008. Available from <http://www.abstractsonline.com/Plan/ViewSession.aspx?sKey=9f0145ff-534c>4a96-9cab-0df88ee864dc
Dafny N, 1990, NIDA Res Monogr, 105, 553
10.1016/S0168-0102(00)00226-1
Hutchinson MR, 2007, Sci World J, 7, 98, 10.1100/tsw.2007.230
Hutchinson MR, 2008, Brain Behav Immun, 22, 1178, 10.1016/j.bbi.2008.05.004
10.1016/j.bbi.2008.09.012
Bonci A, 2003, Trends Pharmacol Sci, 24, 172, 10.1016/S0165-6147(03)00068-3
10.1016/j.bbi.2009.01.014
Takagi K, 1985, Appl Pharmacol (Japan), 30, 967
Nagatsu Y, 1990, Chem Pharm Bull (Tokyo), 38, 400, 10.1248/cpb.38.400
Rolan P, 2008, Br J Clin Pharmacol, 66, 792, 10.1111/j.1365-2125.2008.03270.x
Shida T, 1985, Kiso to Rinsho, 19, 65
Sone H, 1995, Angiology, 46, 699, 10.1177/000331979504600808
Inoue N, 2008, Zrzeneimittelforschung, 58, 277
Rolan P. Methods for targeting glial activation in the treatment of patients with chronic pain. Presented at the Mechanisms and Treatment of Neuropathic Pain Annual Meeting. Snowbird, Utah, USA, Nov 2007
